Eli Lilly & Co |
11.14% |
AbbVie Inc |
6.36% |
Novo Nordisk A/S |
5.24% |
AstraZeneca PLC |
4.92% |
Abbott Laboratories |
4.53% |
UnitedHealth Group Inc |
4.21% |
Roche Holding AG |
4.20% |
Bristol-Myers Squibb Co |
3.66% |
Thermo Fisher Scientific Inc |
3.58% |
Intuitive Surgical Inc |
3.56% |
Johnson & Johnson |
3.44% |
Zoetis Inc |
3.14% |
Boston Scientific Corp |
2.92% |
Gilead Sciences Inc |
2.63% |
Sanofi |
2.50% |
Danaher Corp |
2.49% |
Vertex Pharmaceuticals Inc |
2.48% |
CSL Ltd |
1.92% |
McKesson Corp |
1.79% |
Lonza Group AG |
1.47% |
Edwards Lifesciences Corp |
1.47% |
IDEXX Laboratories Inc |
1.46% |
Mettler-Toledo International Inc |
1.39% |
Humana Inc |
1.32% |
Neurocrine Biosciences Inc |
1.26% |
Merck & Co Inc |
1.19% |
Cooper Cos Inc |
1.18% |
Alcon AG |
1.18% |
Stryker Corp |
1.17% |
Royalty Pharma PLC |
1.10% |
Straumann Holding AG |
1.00% |
Centene Corp |
0.97% |
ARGENX SE - ADR |
0.97% |
SPDR S&P Biotech ETF |
0.94% |
Coloplast A/S |
0.88% |
Amplifon SpA |
0.81% |
Align Technology Inc |
0.79% |
Sartorius AG |
0.78% |
Teleflex Inc |
0.70% |
AptarGroup Inc |
0.67% |
Option Care Health Inc |
0.61% |
Illumina Inc |
0.54% |
Asahi Intecc Co Ltd |
0.43% |
Newamsterdam Pharma Co NV |
0.25% |
iShares Global Healthcare ETF |
0.19% |
JMDC Inc |
0.17% |
MSILF GOVERNMENT PORTFOLIO MSILF GOVERNMENT PORTFOLIO |
0.11% |
CARIS LIFE SCIENCES, INC |
0.06% |